SCHEMBL616847

SCHEMBL616847

CC(C)NCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11666694 0.77
SCHEMBL1719639 0.74
SCHEMBL2058389 0.74
SCHEMBL22385121 0.72
SCHEMBL7952164 0.72
SCHEMBL1805609 0.72
SCHEMBL1843433 0.72
SCHEMBL143017 0.72
SCHEMBL7071831 0.72
SCHEMBL1488634 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103998488-B Process for making hybrid polyester-polyether polyols 陶氏环球技术有限责任公司 2017-05-24 CN claimed
US-20230159498-A1 SMALL MOLECULES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND CANCER ATHOS THERAPEUTICS, INC. 2023-05-25 US disclosed
CN-114746400-A Compounds useful as selective androgen receptor modulators 南京明德新药研发有限公司 2022-07-12 CN disclosed
CN-114728904-A Bicyclic compounds as selective androgen receptor modulators 南京明德新药研发有限公司 2022-07-08 CN disclosed
CN-114276302-A Method for preparing 2, 4-diamino quinazoline derivative 山东百启生物医药有限公司 2022-04-05 CN disclosed
WO-2021241810-A1 GLP-1 HAVING HSA SITE-SPECIFICALLY LINKED THERETO 주식회사 프로앱텍 2021-12-02 WO disclosed
EP-3191471-B1 4,5-DIHYDROPYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND (DE) 2020-03-11 EP disclosed
US-20190290645-A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2019-09-26 US disclosed
US-20190290632-A1 Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2019-09-26 US disclosed
EP-3057958-B1 AMINOTETRALINE AND AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY ABBVIE DEUTSCHLAND (DE) 2019-05-01 EP disclosed
US-5053548-A Containing hydroxy substituents; nervous system disorders OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-01 US disclosed
EP-0442638-A2 Polymeric compounds Du Pont (UK) Limited (GB) 1991-08-21 EP disclosed
EP-0382213-A2 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
EP-0358400-A2 Improvements in or relating to polymeric compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-14 EP disclosed
EP-0318859-A2 N-substituted mercaptopropanamide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1989-06-07 EP disclosed
US-4477372-A DETERGENTS HENKEL CORPORATION (US) 1984-10-16 US disclosed
US-4476044-A Surfactant product HENKEL CORPORATION (US) 1984-10-09 US disclosed
US-4476043-A BLEND OF ALKANOLAMIDE WITH HYDROXYLAMINE NEUTRALIZED ORGANIC SULFATE OR SULFONATE HENKEL CORPORATION (US) 1984-10-09 US disclosed
US-4476045-A HYDROXYAMINE SULFATE OR SULFONATE HENKEL CORPORATION (US) 1984-10-09 US disclosed